Treatment outcomes of HIV-positive patients on first-line antiretroviral therapy in private versus public HIV clinics in Johannesburg, South Africa

被引:16
|
作者
Moyo, Faith [1 ]
Chasela, Charles [2 ,3 ]
Brennan, Alana T. [1 ,4 ]
Ebrahim, Osman [5 ]
Sanne, Ian M. [1 ,6 ]
Long, Lawrence [1 ]
Evans, Denise [1 ]
机构
[1] Univ Witwatersrand, Hlth Econ & Epidemiol Res Off, Dept Internal Med, Sch Clin Med,Fac Hlth Sci, Unit 2,39 Empire Rd, ZA-2193 Johannesburg, South Africa
[2] Univ Witwatersrand, Sch Publ Hlth, Epidemiol & Biostat Dept, Fac Hlth Sci, Johannesburg, South Africa
[3] Human Sci Res Council, Epidemiol & Strateg Informat ESI HIV AIDS STIs &, Pretoria, South Africa
[4] Boston Univ, Ctr Global Hlth & Dev, Boston, MA 02215 USA
[5] Brenthurst Clin, Parktown, South Africa
[6] Right To Care, Helen Joseph Hosp, Johannesburg, South Africa
来源
CLINICAL EPIDEMIOLOGY | 2016年 / 8卷
关键词
health systems; attrition; HIV programs; viral suppression; SUB-SAHARAN AFRICA; EARLY MORTALITY; FOLLOW-UP; CARE; PROGRAM; ADHERENCE; SECTOR; COHORT; INDIA; RISK;
D O I
10.2147/CLEP.S93014
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Despite the widely documented success of antiretroviral therapy(ART), stakeholders continue to face the challenges of poor HIV treatment outcomes. While many studies have investigated patient-level causes of poor treatment outcomes, data on the effect of health systems on ART outcomes are scarce. Objective: We compare treatment outcomes among patients receiving HIV care and treatment at a public and private HIV clinic in Johannesburg, South Africa. Patients and methods: This was a retrospective cohort analysis of ART naive adults (>= 18.0 years), initiating ART at a public or private clinic in Johannesburg between July 01, 2007 and December 31, 2012. Cox proportional-hazards regression was used to identify baseline predictors of mortality and loss to follow-up (>3 months late for the last scheduled visit). Generalized estimating equations were used to determine predictors of failure to suppress viral load (>= 400 copies/mL) while the Wilcoxon rank-sum test was used to compare the median absolute change in CD4 count from baseline to 12 months post-ART initiation. Results: 12,865 patients initiated ART at the public clinic compared to 610 at the private clinic. The patients were similar in terms of sex and age at initiation. Compared to public clinic patients, private clinic patients initiated ART at higher median CD4 counts(159 vs 113 cells/mm(3)) and World Health Organization stage I/II(76.1% vs 58.5%). Adjusted hazard models showed that compared to public clinic patients, private clinic patients were less likely to die(adjusted hazard ratio [aHR] 0.50; 95% confidence interval [CI] 0.35-0.70) but were at increased risk of loss to follow-up(aHR 1.80; 95% CI 1.59-2.03). By 12 months post-ART initiation, private clinic patients were less likely to have a detectable viral load(adjusted relative risk 0.65; 95% CI 0.49-0.88) and recorded higher median CD4 change from baseline(184 cells/mm(3) interquartile range 101-300 vs 158 cells/mm3 interquartile range 91-244), when compared to public clinic patients. Conclusion: We identified differences in treatment outcomes between the two HIV clinics. Findings suggest that the type of clinic at which ART patients initiate and receive treatment can have an impact on treatment outcomes. Further research is necessary to provide more conclusive results.
引用
收藏
页码:37 / 46
页数:10
相关论文
共 50 条
  • [41] The association between depression and adherence to antiretroviral therapy in HIV-positive patients, KwaZulu-Natal, South Africa
    Kitshoff, C.
    Naidoo, S. S.
    SOUTH AFRICAN FAMILY PRACTICE, 2012, 54 (02) : 145 - 150
  • [42] Patterns of detectable viral load in a cohort of HIV-positive adolescents on antiretroviral therapy in South Africa
    Sher, Rebecca
    Dlamini, Sipho
    Muloiwa, Rudzani
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2020, 23 (03)
  • [43] Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia
    Bezabih, Yihienew Mequanint
    Beyene, Fekadu
    Bezabhe, Woldesellassie M.
    BMC INFECTIOUS DISEASES, 2019, 19 (1)
  • [44] Factors associated with first-line antiretroviral treatment failure in adult HIV-positive patients: a case-control study from Ethiopia
    Yihienew Mequanint Bezabih
    Fekadu Beyene
    Woldesellassie M. Bezabhe
    BMC Infectious Diseases, 19
  • [45] Outcomes of a nurse-managed service for stable HIV-positive patients in a large South African public sector antiretroviral therapy programme
    Grimsrud, Anna
    Kaplan, Richard
    Bekker, Linda-Gail
    Myer, Landon
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2014, 19 (09) : 1029 - 1039
  • [46] Quality of life among HIV-positive patients pretreatment in comparison with HIV-positive patients on antiretroviral treatment.
    Ahmedi, Y.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2007, 55 (01) : S144 - S145
  • [47] Frequency of resistance to first-line antiretroviral therapy observed among HIV patients
    Khan, Feroz
    Bilal, Muhammad
    Khan, Muhammad Yaseen
    Fareezuddin, Mian
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2022, 38 (07)
  • [48] Health outcomes among HIV-positive Latinos initiating antiretroviral therapy in North America versus Central and South America
    Cesar, Carina
    Koethe, John R.
    Giganti, Mark J.
    Rebeiro, Peter
    Althoff, Keri N.
    Napravnik, Sonia
    Mayor, Angel
    Grinsztejn, Beatriz
    Wolff, Marcelo
    Padgett, Denis
    Sierra-Madero, Juan
    Gotuzzo, Eduardo
    Sterling, Timothy R.
    Willig, James
    Levison, Julie
    Kitahata, Mari
    Rodriguez-Barradas, Maria C.
    Moore, Richard D.
    McGowan, Catherine
    Shepherd, Bryan E.
    Cahn, Pedro
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [49] Treatment outcomes of over 1000 patients on second-line, protease inhibitor-based antiretroviral therapy from four public-sector HIV treatment facilities across Johannesburg, South Africa
    Shearer, Kate
    Evans, Denise
    Moyo, Faith
    Rohr, Julia K.
    Berhanu, Rebecca
    Van den Berg, Liudmyla
    Long, Lawrence
    Sanne, Ian
    Fox, Matthew P.
    TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2017, 22 (02) : 221 - 231
  • [50] Pretreatment HIV Drug Resistance and Virologic Outcomes to First-Line Antiretroviral Therapy in Peru
    Soria, Jaime
    Mugruza, Raquel
    Levine, Molly
    Leon, Segundo R.
    Arevalo, Jorge
    Ticona, Eduardo
    Beck, Ingrid A.
    Frenkel, Lisa M.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2019, 35 (02) : 150 - 154